カテゴリー： LP Information, 世界, 医療/バイオ

止血剤＆組織シーリング剤のグローバル市場予測2023-2029

◆英語タイトル：Global Hemostatic and Tissue Sealing Agents Market Growth 2023-2029

LP Informationが発行した調査報告書（LP23MY4847）◆商品コード：LP23MY4847
◆発行会社（リサーチ会社）：LP Information
◆発行日：2023年5月
◆ページ数：112
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
◆産業分野：医療機器＆消耗品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥556,320見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥834,480見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,112,640見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

LP Informationの最新刊調査レポート「止血剤＆組織シーリング剤のグローバル市場」は、過去の販売実績から2022年の世界の止血剤＆組織シーリング剤の総販売量を検討し、2023年から2029年の予測される止血剤＆組織シーリング剤の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別の止血剤＆組織シーリング剤の市場規模を掲載し、XXX百万米ドル規模の世界の止血剤＆組織シーリング剤市場の詳細な分析を提供します。本インサイトレポートは、世界の止血剤＆組織シーリング剤業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界の止血剤＆組織シーリング剤市場における各社の独自のポジションをより深く理解するために、止血剤＆組織シーリング剤製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界の止血剤＆組織シーリング剤市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。止血剤＆組織シーリング剤の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。止血剤＆組織シーリング剤の中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。止血剤＆組織シーリング剤のヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

止血剤＆組織シーリング剤の世界主要メーカーとしては、J&J、 Baxter、 C R Bard、 B Braun、 Integra Life Sciences、 Advance Medical Solution、 CSL Behring、 CryoLife、 Zimmer Biomet、 Pfizer、 Medtronic、 Smith & Nephew、 Cohera Medical、 Shanghai Haohai Biological Technology Co. Ltd.、 Shandong Saikesaisi Biotechnology Co., Ltd、 Chang ShaHai Run biological technology Co, LTDなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別の止血剤＆組織シーリング剤市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場セグメンテーション】

この調査では止血剤＆組織シーリング剤市場をセグメンテーションし、種類別 (止血剤、シーラントガム)、用途別 (低侵襲手術、一般外科、その他)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：止血剤、シーラントガム

・用途別区分：低侵襲手術、一般外科、その他

・地域別区分
南北アメリカ（米国、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界の止血剤＆組織シーリング剤市場の10年間の市場状況・展望は？
・世界および地域別に見た止血剤＆組織シーリング剤市場成長の要因は何か？
・止血剤＆組織シーリング剤の市場機会はエンドマーケットの規模によってどのように変化するのか？
・止血剤＆組織シーリング剤のタイプ別、用途別の内訳は？
・新型コロナウイルスとロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：止血剤＆組織シーリング剤の年間販売量2018-2029、地域別現状・将来分析
・止血剤＆組織シーリング剤の種類別セグメント：止血剤、シーラントガム
・止血剤＆組織シーリング剤の種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・止血剤＆組織シーリング剤の用途別セグメント：低侵襲手術、一般外科、その他
・止血剤＆組織シーリング剤の用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界の止血剤＆組織シーリング剤市場
・企業別のグローバル止血剤＆組織シーリング剤市場データ：2018-2023年の年間販売量、市場シェア
・企業別の止血剤＆組織シーリング剤の年間売上：2018-2023年の売上、市場シェア
・企業別の止血剤＆組織シーリング剤販売価格
・主要企業の止血剤＆組織シーリング剤生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

止血剤＆組織シーリング剤の地域別レビュー
・地域別の止血剤＆組織シーリング剤市場規模2018-2023：年間販売量、売上
・主要国別の止血剤＆組織シーリング剤市場規模2018-2023：年間販売量、売上
・南北アメリカの止血剤＆組織シーリング剤販売の成長
・アジア太平洋の止血剤＆組織シーリング剤販売の成長
・ヨーロッパの止血剤＆組織シーリング剤販売の成長
・中東・アフリカの止血剤＆組織シーリング剤販売の成長

南北アメリカ市場
・南北アメリカの国別の止血剤＆組織シーリング剤販売量、売上（2018-2023）
・南北アメリカの止血剤＆組織シーリング剤の種類別販売量
・南北アメリカの止血剤＆組織シーリング剤の用途別販売量
・米国市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別の止血剤＆組織シーリング剤販売量、売上（2018-2023）
・アジア太平洋の止血剤＆組織シーリング剤の種類別販売量
・アジア太平洋の止血剤＆組織シーリング剤の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別の止血剤＆組織シーリング剤販売量、売上（2018-2023）
・ヨーロッパの止血剤＆組織シーリング剤の種類別販売量
・ヨーロッパの止血剤＆組織シーリング剤の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別の止血剤＆組織シーリング剤販売量、売上（2018-2023）
・中東・アフリカの止血剤＆組織シーリング剤の種類別販売量
・中東・アフリカの止血剤＆組織シーリング剤の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・止血剤＆組織シーリング剤の製造コスト構造分析
・止血剤＆組織シーリング剤の製造プロセス分析
・止血剤＆組織シーリング剤の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・止血剤＆組織シーリング剤の主要なグローバル販売業者
・止血剤＆組織シーリング剤の主要なグローバル顧客

地域別の止血剤＆組織シーリング剤市場予測レビュー
・地域別の止血剤＆組織シーリング剤市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・止血剤＆組織シーリング剤の種類別市場規模予測
・止血剤＆組織シーリング剤の用途別市場規模予測

主要企業分析
J&J、 Baxter、 C R Bard、 B Braun、 Integra Life Sciences、 Advance Medical Solution、 CSL Behring、 CryoLife、 Zimmer Biomet、 Pfizer、 Medtronic、 Smith & Nephew、 Cohera Medical、 Shanghai Haohai Biological Technology Co. Ltd.、 Shandong Saikesaisi Biotechnology Co., Ltd、 Chang ShaHai Run biological technology Co, LTD
・企業情報
・止血剤＆組織シーリング剤製品
・止血剤＆組織シーリング剤販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

Hemostasis is defined as “the blocking of bleeding or bleeding through blood vessels or other parts of the body”.Hemostatic agents and tissue adhesives are used as an adjunct or alternative to standard suture techniques to control bleeding or wound closure.The industry is driven by a growing base of older people and an increase in the prevalence of chronic diseases.More than 45 percent of americans have at least one chronic condition that requires intensive care, according to the CDC.Elderly patients require intensive care, are prone to injury and take a long time to heal.Chronic diseases eventually lead to surgery for patients, which in turn promotes the development of the hemostasis and tissue sealant industries.
LPI (LP Information)’ newest research report, the “Hemostatic and Tissue Sealing Agents Industry Forecast” looks at past sales and reviews total world Hemostatic and Tissue Sealing Agents sales in 2022, providing a comprehensive analysis by region and market sector of projected Hemostatic and Tissue Sealing Agents sales for 2023 through 2029. With Hemostatic and Tissue Sealing Agents sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Hemostatic and Tissue Sealing Agents industry.
This Insight Report provides a comprehensive analysis of the global Hemostatic and Tissue Sealing Agents landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Hemostatic and Tissue Sealing Agents portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Hemostatic and Tissue Sealing Agents market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Hemostatic and Tissue Sealing Agents and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Hemostatic and Tissue Sealing Agents.
The global Hemostatic and Tissue Sealing Agents market size is projected to grow from US$ 2740.9 million in 2022 to US$ 3396.7 million in 2029; it is expected to grow at a CAGR of 3396.7 from 2023 to 2029.
Global Hemostatic and Tissue Sealing Agents key players include J&J, Baxter, C R Bard, etc. Global top three manufacturers hold a share over 45%.
North America is the largest market, with a share about 60%, followed by China, and Europe, both have a share about 30 percent.
In terms of product, Hemostatic is the largest segment, with a share about 75%. And in terms of application, the largest application is General Surgery, followed by Minimally Invasive Surgery, etc.
This report presents a comprehensive overview, market shares, and growth opportunities of Hemostatic and Tissue Sealing Agents market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Hemostatic
Sealant Gum
Segmentation by application
Minimally Invasive Surgery
General Surgery
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
J&J
Baxter
C R Bard
B Braun
Integra Life Sciences
Advance Medical Solution
CSL Behring
CryoLife
Zimmer Biomet
Pfizer
Medtronic
Smith & Nephew
Cohera Medical
Shanghai Haohai Biological Technology Co. Ltd.
Shandong Saikesaisi Biotechnology Co., Ltd
Chang ShaHai Run biological technology Co, LTD
Key Questions Addressed in this Report
What is the 10-year outlook for the global Hemostatic and Tissue Sealing Agents market?
What factors are driving Hemostatic and Tissue Sealing Agents market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Hemostatic and Tissue Sealing Agents market opportunities vary by end market size?
How does Hemostatic and Tissue Sealing Agents break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Hemostatic and Tissue Sealing Agents Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Hemostatic and Tissue Sealing Agents by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Hemostatic and Tissue Sealing Agents by Country/Region, 2018, 2022 & 2029
2.2 Hemostatic and Tissue Sealing Agents Segment by Type
2.2.1 Hemostatic
2.2.2 Sealant Gum
2.3 Hemostatic and Tissue Sealing Agents Sales by Type
2.3.1 Global Hemostatic and Tissue Sealing Agents Sales Market Share by Type (2018-2023)
2.3.2 Global Hemostatic and Tissue Sealing Agents Revenue and Market Share by Type (2018-2023)
2.3.3 Global Hemostatic and Tissue Sealing Agents Sale Price by Type (2018-2023)
2.4 Hemostatic and Tissue Sealing Agents Segment by Application
2.4.1 Minimally Invasive Surgery
2.4.2 General Surgery
2.4.3 Other
2.5 Hemostatic and Tissue Sealing Agents Sales by Application
2.5.1 Global Hemostatic and Tissue Sealing Agents Sale Market Share by Application (2018-2023)
2.5.2 Global Hemostatic and Tissue Sealing Agents Revenue and Market Share by Application (2018-2023)
2.5.3 Global Hemostatic and Tissue Sealing Agents Sale Price by Application (2018-2023)
3 Global Hemostatic and Tissue Sealing Agents by Company
3.1 Global Hemostatic and Tissue Sealing Agents Breakdown Data by Company
3.1.1 Global Hemostatic and Tissue Sealing Agents Annual Sales by Company (2018-2023)
3.1.2 Global Hemostatic and Tissue Sealing Agents Sales Market Share by Company (2018-2023)
3.2 Global Hemostatic and Tissue Sealing Agents Annual Revenue by Company (2018-2023)
3.2.1 Global Hemostatic and Tissue Sealing Agents Revenue by Company (2018-2023)
3.2.2 Global Hemostatic and Tissue Sealing Agents Revenue Market Share by Company (2018-2023)
3.3 Global Hemostatic and Tissue Sealing Agents Sale Price by Company
3.4 Key Manufacturers Hemostatic and Tissue Sealing Agents Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Hemostatic and Tissue Sealing Agents Product Location Distribution
3.4.2 Players Hemostatic and Tissue Sealing Agents Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Hemostatic and Tissue Sealing Agents by Geographic Region
4.1 World Historic Hemostatic and Tissue Sealing Agents Market Size by Geographic Region (2018-2023)
4.1.1 Global Hemostatic and Tissue Sealing Agents Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Hemostatic and Tissue Sealing Agents Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Hemostatic and Tissue Sealing Agents Market Size by Country/Region (2018-2023)
4.2.1 Global Hemostatic and Tissue Sealing Agents Annual Sales by Country/Region (2018-2023)
4.2.2 Global Hemostatic and Tissue Sealing Agents Annual Revenue by Country/Region (2018-2023)
4.3 Americas Hemostatic and Tissue Sealing Agents Sales Growth
4.4 APAC Hemostatic and Tissue Sealing Agents Sales Growth
4.5 Europe Hemostatic and Tissue Sealing Agents Sales Growth
4.6 Middle East & Africa Hemostatic and Tissue Sealing Agents Sales Growth
5 Americas
5.1 Americas Hemostatic and Tissue Sealing Agents Sales by Country
5.1.1 Americas Hemostatic and Tissue Sealing Agents Sales by Country (2018-2023)
5.1.2 Americas Hemostatic and Tissue Sealing Agents Revenue by Country (2018-2023)
5.2 Americas Hemostatic and Tissue Sealing Agents Sales by Type
5.3 Americas Hemostatic and Tissue Sealing Agents Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Hemostatic and Tissue Sealing Agents Sales by Region
6.1.1 APAC Hemostatic and Tissue Sealing Agents Sales by Region (2018-2023)
6.1.2 APAC Hemostatic and Tissue Sealing Agents Revenue by Region (2018-2023)
6.2 APAC Hemostatic and Tissue Sealing Agents Sales by Type
6.3 APAC Hemostatic and Tissue Sealing Agents Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Hemostatic and Tissue Sealing Agents by Country
7.1.1 Europe Hemostatic and Tissue Sealing Agents Sales by Country (2018-2023)
7.1.2 Europe Hemostatic and Tissue Sealing Agents Revenue by Country (2018-2023)
7.2 Europe Hemostatic and Tissue Sealing Agents Sales by Type
7.3 Europe Hemostatic and Tissue Sealing Agents Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Hemostatic and Tissue Sealing Agents by Country
8.1.1 Middle East & Africa Hemostatic and Tissue Sealing Agents Sales by Country (2018-2023)
8.1.2 Middle East & Africa Hemostatic and Tissue Sealing Agents Revenue by Country (2018-2023)
8.2 Middle East & Africa Hemostatic and Tissue Sealing Agents Sales by Type
8.3 Middle East & Africa Hemostatic and Tissue Sealing Agents Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Hemostatic and Tissue Sealing Agents
10.3 Manufacturing Process Analysis of Hemostatic and Tissue Sealing Agents
10.4 Industry Chain Structure of Hemostatic and Tissue Sealing Agents
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Hemostatic and Tissue Sealing Agents Distributors
11.3 Hemostatic and Tissue Sealing Agents Customer
12 World Forecast Review for Hemostatic and Tissue Sealing Agents by Geographic Region
12.1 Global Hemostatic and Tissue Sealing Agents Market Size Forecast by Region
12.1.1 Global Hemostatic and Tissue Sealing Agents Forecast by Region (2024-2029)
12.1.2 Global Hemostatic and Tissue Sealing Agents Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Hemostatic and Tissue Sealing Agents Forecast by Type
12.7 Global Hemostatic and Tissue Sealing Agents Forecast by Application
13 Key Players Analysis
13.1 J&J
13.1.1 J&J Company Information
13.1.2 J&J Hemostatic and Tissue Sealing Agents Product Portfolios and Specifications
13.1.3 J&J Hemostatic and Tissue Sealing Agents Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 J&J Main Business Overview
13.1.5 J&J Latest Developments
13.2 Baxter
13.2.1 Baxter Company Information
13.2.2 Baxter Hemostatic and Tissue Sealing Agents Product Portfolios and Specifications
13.2.3 Baxter Hemostatic and Tissue Sealing Agents Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Baxter Main Business Overview
13.2.5 Baxter Latest Developments
13.3 C R Bard
13.3.1 C R Bard Company Information
13.3.2 C R Bard Hemostatic and Tissue Sealing Agents Product Portfolios and Specifications
13.3.3 C R Bard Hemostatic and Tissue Sealing Agents Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 C R Bard Main Business Overview
13.3.5 C R Bard Latest Developments
13.4 B Braun
13.4.1 B Braun Company Information
13.4.2 B Braun Hemostatic and Tissue Sealing Agents Product Portfolios and Specifications
13.4.3 B Braun Hemostatic and Tissue Sealing Agents Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 B Braun Main Business Overview
13.4.5 B Braun Latest Developments
13.5 Integra Life Sciences
13.5.1 Integra Life Sciences Company Information
13.5.2 Integra Life Sciences Hemostatic and Tissue Sealing Agents Product Portfolios and Specifications
13.5.3 Integra Life Sciences Hemostatic and Tissue Sealing Agents Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Integra Life Sciences Main Business Overview
13.5.5 Integra Life Sciences Latest Developments
13.6 Advance Medical Solution
13.6.1 Advance Medical Solution Company Information
13.6.2 Advance Medical Solution Hemostatic and Tissue Sealing Agents Product Portfolios and Specifications
13.6.3 Advance Medical Solution Hemostatic and Tissue Sealing Agents Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Advance Medical Solution Main Business Overview
13.6.5 Advance Medical Solution Latest Developments
13.7 CSL Behring
13.7.1 CSL Behring Company Information
13.7.2 CSL Behring Hemostatic and Tissue Sealing Agents Product Portfolios and Specifications
13.7.3 CSL Behring Hemostatic and Tissue Sealing Agents Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 CSL Behring Main Business Overview
13.7.5 CSL Behring Latest Developments
13.8 CryoLife
13.8.1 CryoLife Company Information
13.8.2 CryoLife Hemostatic and Tissue Sealing Agents Product Portfolios and Specifications
13.8.3 CryoLife Hemostatic and Tissue Sealing Agents Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 CryoLife Main Business Overview
13.8.5 CryoLife Latest Developments
13.9 Zimmer Biomet
13.9.1 Zimmer Biomet Company Information
13.9.2 Zimmer Biomet Hemostatic and Tissue Sealing Agents Product Portfolios and Specifications
13.9.3 Zimmer Biomet Hemostatic and Tissue Sealing Agents Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Zimmer Biomet Main Business Overview
13.9.5 Zimmer Biomet Latest Developments
13.10 Pfizer
13.10.1 Pfizer Company Information
13.10.2 Pfizer Hemostatic and Tissue Sealing Agents Product Portfolios and Specifications
13.10.3 Pfizer Hemostatic and Tissue Sealing Agents Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Pfizer Main Business Overview
13.10.5 Pfizer Latest Developments
13.11 Medtronic
13.11.1 Medtronic Company Information
13.11.2 Medtronic Hemostatic and Tissue Sealing Agents Product Portfolios and Specifications
13.11.3 Medtronic Hemostatic and Tissue Sealing Agents Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Medtronic Main Business Overview
13.11.5 Medtronic Latest Developments
13.12 Smith & Nephew
13.12.1 Smith & Nephew Company Information
13.12.2 Smith & Nephew Hemostatic and Tissue Sealing Agents Product Portfolios and Specifications
13.12.3 Smith & Nephew Hemostatic and Tissue Sealing Agents Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Smith & Nephew Main Business Overview
13.12.5 Smith & Nephew Latest Developments
13.13 Cohera Medical
13.13.1 Cohera Medical Company Information
13.13.2 Cohera Medical Hemostatic and Tissue Sealing Agents Product Portfolios and Specifications
13.13.3 Cohera Medical Hemostatic and Tissue Sealing Agents Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Cohera Medical Main Business Overview
13.13.5 Cohera Medical Latest Developments
13.14 Shanghai Haohai Biological Technology Co. Ltd.
13.14.1 Shanghai Haohai Biological Technology Co. Ltd. Company Information
13.14.2 Shanghai Haohai Biological Technology Co. Ltd. Hemostatic and Tissue Sealing Agents Product Portfolios and Specifications
13.14.3 Shanghai Haohai Biological Technology Co. Ltd. Hemostatic and Tissue Sealing Agents Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Shanghai Haohai Biological Technology Co. Ltd. Main Business Overview
13.14.5 Shanghai Haohai Biological Technology Co. Ltd. Latest Developments
13.15 Shandong Saikesaisi Biotechnology Co., Ltd
13.15.1 Shandong Saikesaisi Biotechnology Co., Ltd Company Information
13.15.2 Shandong Saikesaisi Biotechnology Co., Ltd Hemostatic and Tissue Sealing Agents Product Portfolios and Specifications
13.15.3 Shandong Saikesaisi Biotechnology Co., Ltd Hemostatic and Tissue Sealing Agents Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Shandong Saikesaisi Biotechnology Co., Ltd Main Business Overview
13.15.5 Shandong Saikesaisi Biotechnology Co., Ltd Latest Developments
13.16 Chang ShaHai Run biological technology Co, LTD
13.16.1 Chang ShaHai Run biological technology Co, LTD Company Information
13.16.2 Chang ShaHai Run biological technology Co, LTD Hemostatic and Tissue Sealing Agents Product Portfolios and Specifications
13.16.3 Chang ShaHai Run biological technology Co, LTD Hemostatic and Tissue Sealing Agents Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Chang ShaHai Run biological technology Co, LTD Main Business Overview
13.16.5 Chang ShaHai Run biological technology Co, LTD Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Hemostatic and Tissue Sealing Agents Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Hemostatic and Tissue Sealing Agents Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Hemostatic
Table 4. Major Players of Sealant Gum
Table 5. Global Hemostatic and Tissue Sealing Agents Sales by Type (2018-2023) & (K Units)
Table 6. Global Hemostatic and Tissue Sealing Agents Sales Market Share by Type (2018-2023)
Table 7. Global Hemostatic and Tissue Sealing Agents Revenue by Type (2018-2023) & ($ million)
Table 8. Global Hemostatic and Tissue Sealing Agents Revenue Market Share by Type (2018-2023)
Table 9. Global Hemostatic and Tissue Sealing Agents Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Hemostatic and Tissue Sealing Agents Sales by Application (2018-2023) & (K Units)
Table 11. Global Hemostatic and Tissue Sealing Agents Sales Market Share by Application (2018-2023)
Table 12. Global Hemostatic and Tissue Sealing Agents Revenue by Application (2018-2023)
Table 13. Global Hemostatic and Tissue Sealing Agents Revenue Market Share by Application (2018-2023)
Table 14. Global Hemostatic and Tissue Sealing Agents Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Hemostatic and Tissue Sealing Agents Sales by Company (2018-2023) & (K Units)
Table 16. Global Hemostatic and Tissue Sealing Agents Sales Market Share by Company (2018-2023)
Table 17. Global Hemostatic and Tissue Sealing Agents Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Hemostatic and Tissue Sealing Agents Revenue Market Share by Company (2018-2023)
Table 19. Global Hemostatic and Tissue Sealing Agents Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Hemostatic and Tissue Sealing Agents Producing Area Distribution and Sales Area
Table 21. Players Hemostatic and Tissue Sealing Agents Products Offered
Table 22. Hemostatic and Tissue Sealing Agents Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Hemostatic and Tissue Sealing Agents Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Hemostatic and Tissue Sealing Agents Sales Market Share Geographic Region (2018-2023)
Table 27. Global Hemostatic and Tissue Sealing Agents Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Hemostatic and Tissue Sealing Agents Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Hemostatic and Tissue Sealing Agents Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Hemostatic and Tissue Sealing Agents Sales Market Share by Country/Region (2018-2023)
Table 31. Global Hemostatic and Tissue Sealing Agents Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Hemostatic and Tissue Sealing Agents Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Hemostatic and Tissue Sealing Agents Sales by Country (2018-2023) & (K Units)
Table 34. Americas Hemostatic and Tissue Sealing Agents Sales Market Share by Country (2018-2023)
Table 35. Americas Hemostatic and Tissue Sealing Agents Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Hemostatic and Tissue Sealing Agents Revenue Market Share by Country (2018-2023)
Table 37. Americas Hemostatic and Tissue Sealing Agents Sales by Type (2018-2023) & (K Units)
Table 38. Americas Hemostatic and Tissue Sealing Agents Sales by Application (2018-2023) & (K Units)
Table 39. APAC Hemostatic and Tissue Sealing Agents Sales by Region (2018-2023) & (K Units)
Table 40. APAC Hemostatic and Tissue Sealing Agents Sales Market Share by Region (2018-2023)
Table 41. APAC Hemostatic and Tissue Sealing Agents Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Hemostatic and Tissue Sealing Agents Revenue Market Share by Region (2018-2023)
Table 43. APAC Hemostatic and Tissue Sealing Agents Sales by Type (2018-2023) & (K Units)
Table 44. APAC Hemostatic and Tissue Sealing Agents Sales by Application (2018-2023) & (K Units)
Table 45. Europe Hemostatic and Tissue Sealing Agents Sales by Country (2018-2023) & (K Units)
Table 46. Europe Hemostatic and Tissue Sealing Agents Sales Market Share by Country (2018-2023)
Table 47. Europe Hemostatic and Tissue Sealing Agents Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Hemostatic and Tissue Sealing Agents Revenue Market Share by Country (2018-2023)
Table 49. Europe Hemostatic and Tissue Sealing Agents Sales by Type (2018-2023) & (K Units)
Table 50. Europe Hemostatic and Tissue Sealing Agents Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Hemostatic and Tissue Sealing Agents Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Hemostatic and Tissue Sealing Agents Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Hemostatic and Tissue Sealing Agents Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Hemostatic and Tissue Sealing Agents Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Hemostatic and Tissue Sealing Agents Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Hemostatic and Tissue Sealing Agents Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Hemostatic and Tissue Sealing Agents
Table 58. Key Market Challenges & Risks of Hemostatic and Tissue Sealing Agents
Table 59. Key Industry Trends of Hemostatic and Tissue Sealing Agents
Table 60. Hemostatic and Tissue Sealing Agents Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Hemostatic and Tissue Sealing Agents Distributors List
Table 63. Hemostatic and Tissue Sealing Agents Customer List
Table 64. Global Hemostatic and Tissue Sealing Agents Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Hemostatic and Tissue Sealing Agents Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Hemostatic and Tissue Sealing Agents Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Hemostatic and Tissue Sealing Agents Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Hemostatic and Tissue Sealing Agents Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Hemostatic and Tissue Sealing Agents Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Hemostatic and Tissue Sealing Agents Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Hemostatic and Tissue Sealing Agents Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Hemostatic and Tissue Sealing Agents Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Hemostatic and Tissue Sealing Agents Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Hemostatic and Tissue Sealing Agents Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Hemostatic and Tissue Sealing Agents Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Hemostatic and Tissue Sealing Agents Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Hemostatic and Tissue Sealing Agents Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. J&J Basic Information, Hemostatic and Tissue Sealing Agents Manufacturing Base, Sales Area and Its Competitors
Table 79. J&J Hemostatic and Tissue Sealing Agents Product Portfolios and Specifications
Table 80. J&J Hemostatic and Tissue Sealing Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. J&J Main Business
Table 82. J&J Latest Developments
Table 83. Baxter Basic Information, Hemostatic and Tissue Sealing Agents Manufacturing Base, Sales Area and Its Competitors
Table 84. Baxter Hemostatic and Tissue Sealing Agents Product Portfolios and Specifications
Table 85. Baxter Hemostatic and Tissue Sealing Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Baxter Main Business
Table 87. Baxter Latest Developments
Table 88. C R Bard Basic Information, Hemostatic and Tissue Sealing Agents Manufacturing Base, Sales Area and Its Competitors
Table 89. C R Bard Hemostatic and Tissue Sealing Agents Product Portfolios and Specifications
Table 90. C R Bard Hemostatic and Tissue Sealing Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. C R Bard Main Business
Table 92. C R Bard Latest Developments
Table 93. B Braun Basic Information, Hemostatic and Tissue Sealing Agents Manufacturing Base, Sales Area and Its Competitors
Table 94. B Braun Hemostatic and Tissue Sealing Agents Product Portfolios and Specifications
Table 95. B Braun Hemostatic and Tissue Sealing Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. B Braun Main Business
Table 97. B Braun Latest Developments
Table 98. Integra Life Sciences Basic Information, Hemostatic and Tissue Sealing Agents Manufacturing Base, Sales Area and Its Competitors
Table 99. Integra Life Sciences Hemostatic and Tissue Sealing Agents Product Portfolios and Specifications
Table 100. Integra Life Sciences Hemostatic and Tissue Sealing Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Integra Life Sciences Main Business
Table 102. Integra Life Sciences Latest Developments
Table 103. Advance Medical Solution Basic Information, Hemostatic and Tissue Sealing Agents Manufacturing Base, Sales Area and Its Competitors
Table 104. Advance Medical Solution Hemostatic and Tissue Sealing Agents Product Portfolios and Specifications
Table 105. Advance Medical Solution Hemostatic and Tissue Sealing Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Advance Medical Solution Main Business
Table 107. Advance Medical Solution Latest Developments
Table 108. CSL Behring Basic Information, Hemostatic and Tissue Sealing Agents Manufacturing Base, Sales Area and Its Competitors
Table 109. CSL Behring Hemostatic and Tissue Sealing Agents Product Portfolios and Specifications
Table 110. CSL Behring Hemostatic and Tissue Sealing Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. CSL Behring Main Business
Table 112. CSL Behring Latest Developments
Table 113. CryoLife Basic Information, Hemostatic and Tissue Sealing Agents Manufacturing Base, Sales Area and Its Competitors
Table 114. CryoLife Hemostatic and Tissue Sealing Agents Product Portfolios and Specifications
Table 115. CryoLife Hemostatic and Tissue Sealing Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. CryoLife Main Business
Table 117. CryoLife Latest Developments
Table 118. Zimmer Biomet Basic Information, Hemostatic and Tissue Sealing Agents Manufacturing Base, Sales Area and Its Competitors
Table 119. Zimmer Biomet Hemostatic and Tissue Sealing Agents Product Portfolios and Specifications
Table 120. Zimmer Biomet Hemostatic and Tissue Sealing Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. Zimmer Biomet Main Business
Table 122. Zimmer Biomet Latest Developments
Table 123. Pfizer Basic Information, Hemostatic and Tissue Sealing Agents Manufacturing Base, Sales Area and Its Competitors
Table 124. Pfizer Hemostatic and Tissue Sealing Agents Product Portfolios and Specifications
Table 125. Pfizer Hemostatic and Tissue Sealing Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. Pfizer Main Business
Table 127. Pfizer Latest Developments
Table 128. Medtronic Basic Information, Hemostatic and Tissue Sealing Agents Manufacturing Base, Sales Area and Its Competitors
Table 129. Medtronic Hemostatic and Tissue Sealing Agents Product Portfolios and Specifications
Table 130. Medtronic Hemostatic and Tissue Sealing Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 131. Medtronic Main Business
Table 132. Medtronic Latest Developments
Table 133. Smith & Nephew Basic Information, Hemostatic and Tissue Sealing Agents Manufacturing Base, Sales Area and Its Competitors
Table 134. Smith & Nephew Hemostatic and Tissue Sealing Agents Product Portfolios and Specifications
Table 135. Smith & Nephew Hemostatic and Tissue Sealing Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 136. Smith & Nephew Main Business
Table 137. Smith & Nephew Latest Developments
Table 138. Cohera Medical Basic Information, Hemostatic and Tissue Sealing Agents Manufacturing Base, Sales Area and Its Competitors
Table 139. Cohera Medical Hemostatic and Tissue Sealing Agents Product Portfolios and Specifications
Table 140. Cohera Medical Hemostatic and Tissue Sealing Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 141. Cohera Medical Main Business
Table 142. Cohera Medical Latest Developments
Table 143. Shanghai Haohai Biological Technology Co. Ltd. Basic Information, Hemostatic and Tissue Sealing Agents Manufacturing Base, Sales Area and Its Competitors
Table 144. Shanghai Haohai Biological Technology Co. Ltd. Hemostatic and Tissue Sealing Agents Product Portfolios and Specifications
Table 145. Shanghai Haohai Biological Technology Co. Ltd. Hemostatic and Tissue Sealing Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 146. Shanghai Haohai Biological Technology Co. Ltd. Main Business
Table 147. Shanghai Haohai Biological Technology Co. Ltd. Latest Developments
Table 148. Shandong Saikesaisi Biotechnology Co., Ltd Basic Information, Hemostatic and Tissue Sealing Agents Manufacturing Base, Sales Area and Its Competitors
Table 149. Shandong Saikesaisi Biotechnology Co., Ltd Hemostatic and Tissue Sealing Agents Product Portfolios and Specifications
Table 150. Shandong Saikesaisi Biotechnology Co., Ltd Hemostatic and Tissue Sealing Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 151. Shandong Saikesaisi Biotechnology Co., Ltd Main Business
Table 152. Shandong Saikesaisi Biotechnology Co., Ltd Latest Developments
Table 153. Chang ShaHai Run biological technology Co, LTD Basic Information, Hemostatic and Tissue Sealing Agents Manufacturing Base, Sales Area and Its Competitors
Table 154. Chang ShaHai Run biological technology Co, LTD Hemostatic and Tissue Sealing Agents Product Portfolios and Specifications
Table 155. Chang ShaHai Run biological technology Co, LTD Hemostatic and Tissue Sealing Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 156. Chang ShaHai Run biological technology Co, LTD Main Business
Table 157. Chang ShaHai Run biological technology Co, LTD Latest Developments
List of Figures
Figure 1. Picture of Hemostatic and Tissue Sealing Agents
Figure 2. Hemostatic and Tissue Sealing Agents Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Hemostatic and Tissue Sealing Agents Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Hemostatic and Tissue Sealing Agents Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Hemostatic and Tissue Sealing Agents Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Hemostatic
Figure 10. Product Picture of Sealant Gum
Figure 11. Global Hemostatic and Tissue Sealing Agents Sales Market Share by Type in 2022
Figure 12. Global Hemostatic and Tissue Sealing Agents Revenue Market Share by Type (2018-2023)
Figure 13. Hemostatic and Tissue Sealing Agents Consumed in Minimally Invasive Surgery
Figure 14. Global Hemostatic and Tissue Sealing Agents Market: Minimally Invasive Surgery (2018-2023) & (K Units)
Figure 15. Hemostatic and Tissue Sealing Agents Consumed in General Surgery
Figure 16. Global Hemostatic and Tissue Sealing Agents Market: General Surgery (2018-2023) & (K Units)
Figure 17. Hemostatic and Tissue Sealing Agents Consumed in Other
Figure 18. Global Hemostatic and Tissue Sealing Agents Market: Other (2018-2023) & (K Units)
Figure 19. Global Hemostatic and Tissue Sealing Agents Sales Market Share by Application (2022)
Figure 20. Global Hemostatic and Tissue Sealing Agents Revenue Market Share by Application in 2022
Figure 21. Hemostatic and Tissue Sealing Agents Sales Market by Company in 2022 (K Units)
Figure 22. Global Hemostatic and Tissue Sealing Agents Sales Market Share by Company in 2022
Figure 23. Hemostatic and Tissue Sealing Agents Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Hemostatic and Tissue Sealing Agents Revenue Market Share by Company in 2022
Figure 25. Global Hemostatic and Tissue Sealing Agents Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Hemostatic and Tissue Sealing Agents Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Hemostatic and Tissue Sealing Agents Sales 2018-2023 (K Units)
Figure 28. Americas Hemostatic and Tissue Sealing Agents Revenue 2018-2023 ($ Millions)
Figure 29. APAC Hemostatic and Tissue Sealing Agents Sales 2018-2023 (K Units)
Figure 30. APAC Hemostatic and Tissue Sealing Agents Revenue 2018-2023 ($ Millions)
Figure 31. Europe Hemostatic and Tissue Sealing Agents Sales 2018-2023 (K Units)
Figure 32. Europe Hemostatic and Tissue Sealing Agents Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Hemostatic and Tissue Sealing Agents Sales 2018-2023 (K Units)
Figure 34. Middle East & Africa Hemostatic and Tissue Sealing Agents Revenue 2018-2023 ($ Millions)
Figure 35. Americas Hemostatic and Tissue Sealing Agents Sales Market Share by Country in 2022
Figure 36. Americas Hemostatic and Tissue Sealing Agents Revenue Market Share by Country in 2022
Figure 37. Americas Hemostatic and Tissue Sealing Agents Sales Market Share by Type (2018-2023)
Figure 38. Americas Hemostatic and Tissue Sealing Agents Sales Market Share by Application (2018-2023)
Figure 39. United States Hemostatic and Tissue Sealing Agents Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Hemostatic and Tissue Sealing Agents Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Hemostatic and Tissue Sealing Agents Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Hemostatic and Tissue Sealing Agents Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Hemostatic and Tissue Sealing Agents Sales Market Share by Region in 2022
Figure 44. APAC Hemostatic and Tissue Sealing Agents Revenue Market Share by Regions in 2022
Figure 45. APAC Hemostatic and Tissue Sealing Agents Sales Market Share by Type (2018-2023)
Figure 46. APAC Hemostatic and Tissue Sealing Agents Sales Market Share by Application (2018-2023)
Figure 47. China Hemostatic and Tissue Sealing Agents Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Hemostatic and Tissue Sealing Agents Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Hemostatic and Tissue Sealing Agents Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Hemostatic and Tissue Sealing Agents Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Hemostatic and Tissue Sealing Agents Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Hemostatic and Tissue Sealing Agents Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Hemostatic and Tissue Sealing Agents Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Hemostatic and Tissue Sealing Agents Sales Market Share by Country in 2022
Figure 55. Europe Hemostatic and Tissue Sealing Agents Revenue Market Share by Country in 2022
Figure 56. Europe Hemostatic and Tissue Sealing Agents Sales Market Share by Type (2018-2023)
Figure 57. Europe Hemostatic and Tissue Sealing Agents Sales Market Share by Application (2018-2023)
Figure 58. Germany Hemostatic and Tissue Sealing Agents Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Hemostatic and Tissue Sealing Agents Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Hemostatic and Tissue Sealing Agents Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Hemostatic and Tissue Sealing Agents Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Hemostatic and Tissue Sealing Agents Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Hemostatic and Tissue Sealing Agents Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Hemostatic and Tissue Sealing Agents Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Hemostatic and Tissue Sealing Agents Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Hemostatic and Tissue Sealing Agents Sales Market Share by Application (2018-2023)
Figure 67. Egypt Hemostatic and Tissue Sealing Agents Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Hemostatic and Tissue Sealing Agents Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Hemostatic and Tissue Sealing Agents Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Hemostatic and Tissue Sealing Agents Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Hemostatic and Tissue Sealing Agents Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Hemostatic and Tissue Sealing Agents in 2022
Figure 73. Manufacturing Process Analysis of Hemostatic and Tissue Sealing Agents
Figure 74. Industry Chain Structure of Hemostatic and Tissue Sealing Agents
Figure 75. Channels of Distribution
Figure 76. Global Hemostatic and Tissue Sealing Agents Sales Market Forecast by Region (2024-2029)
Figure 77. Global Hemostatic and Tissue Sealing Agents Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Hemostatic and Tissue Sealing Agents Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Hemostatic and Tissue Sealing Agents Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Hemostatic and Tissue Sealing Agents Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Hemostatic and Tissue Sealing Agents Revenue Market Share Forecast by Application (2024-2029)


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 止血剤＆組織シーリング剤のグローバル市場予測2023-2029(Global Hemostatic and Tissue Sealing Agents Market Growth 2023-2029)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 一般外科用止血剤のグローバル市場予測2023-2029
  • 創傷手術用止血剤のグローバル市場予測2023-2029
  • 止血ジェルのグローバル市場予測2023-2029
  • ENT（耳鼻咽喉科）手術用止血パッドのグローバル市場予測2023-2029
  • 歯科手術用止血パッドのグローバル市場予測2023-2029

    • ◆H&Iグローバルリサーチのお客様（例）◆